
A British High Court has ruled that AstraZeneca’s patent on its new formulation of the antipsychotic Seroquel is invalid. Seroquel …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

